{"schema_version":"secwatch.filing_event.v1","accession":"0001607062-22-000714","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2022-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.305462+00:00","generated_at":"2026-06-21T15:51:39.370996+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Regen Biopharma issues 101.9M Series A Preferred and 16.9M common shares in debt-for-equity swap","bullets":["Issued 101,880,008 shares of Series A Preferred to satisfy $511,500 convertible debt and $253,816 accrued interest.","Issued 16,912,946 common shares to satisfy $25,369 accrued interest on a convertible note.","Total debt and interest converted: $790,685 ($511,500 principal + $279,185 interest).","Securities issued under Section 4(a)(2) private placement exemption; no underwriters or commissions."],"urls":{"canonical":"https://secwatch.observer/filing/0001607062-22-000714","json":"https://secwatch.observer/filing/0001607062-22-000714.json","markdown":"https://secwatch.observer/filing/0001607062-22-000714.md","text":"https://secwatch.observer/filing/0001607062-22-000714.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000160706222000714/0001607062-22-000714-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000160706222000714/rgbp111822form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T15:51:39.370996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}